title: Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South Africa.
abstract: Numerous reports have documented isolated transmission events or clonal outbreaks of multidrug-resistant Mycobacterium tuberculosis strains, but knowledge of their epidemic spread remains limited. In this study, we evaluated drug resistance, strain diversity, and clustering rates in patients diagnosed with multidrug-resistant (MDR) tuberculosis (TB) at the National Health Laboratory Service (NHLS) Central TB Laboratory in Johannesburg, South Africa, between March 2004 and December 2007. Phenotypic drug susceptibility testing was done using the indirect proportion method, while each isolate was genotyped using a combination of spoligotyping and 12-MIRU typing (12-locus multiple interspersed repetitive unit typing). Isolates from 434 MDR-TB patients were evaluated, of which 238 (54.8%) were resistant to four first-line drugs (isoniazid, rifampin, ethambutol, and streptomycin). Spoligotyping identified 56 different strains and 28 clusters of variable size (2 to 71 cases per cluster) with a clustering rate of 87.1%. Ten clusters included 337 (77.6%) of all cases, with strains of the Beijing genotype being most prevalent (16.4%). Combined analysis of spoligotyping and 12-MIRU typing increased the discriminatory power (Hunter Gaston discriminatory index [HGDI] = 0.962) and reduced the clustering rate to 66.8%. Resolution of Beijing genotype strains was further enhanced with the 24-MIRU-VNTR (variable-number tandem repeat) typing method by identifying 15 subclusters and 19 unique strains from twelve 12-MIRU clusters. High levels of clustering among a variety of strains suggest a true epidemic spread of MDR-TB in the study setting, emphasizing the urgency of early diagnosis and effective treatment to reduce transmission within this community.
authors.affiliation: Sydney Emerging Infectious Diseases and Biosecurity Institute, the University of Sydney, Sydney, Australia.
authors.forename: Ben J
authors.initials: BJ
authors.lastname: Marais
authors.forename: Charmaine K
authors.initials: CK
authors.lastname: Mlambo
authors.forename: Nalin
authors.initials: N
authors.lastname: Rastogi
authors.forename: Thierry
authors.initials: T
authors.lastname: Zozio
authors.forename: Adriano G
authors.initials: AG
authors.lastname: Duse
authors.forename: Thomas C
authors.initials: TC
authors.lastname: Victor
authors.forename: Else
authors.initials: E
authors.lastname: Marais
authors.forename: Robin M
authors.initials: RM
authors.lastname: Warren
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000995:Antitubercular Agents / Q000494:pharmacology; D002648:Child; D002675:Child, Preschool; D016000:Cluster Analysis; D024901:Drug Resistance, Multiple, Bacterial; D058872:Epidemics; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D058889:Molecular Typing; D009169:Mycobacterium tuberculosis / Q000145:classification / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D013019:South Africa / Q000453:epidemiology; D018088:Tuberculosis, Multidrug-Resistant / Q000453:epidemiology* / Q000382:microbiology*; D055815:Young Adult
chemical_list: D000995:Antitubercular Agents
references.citation: Clin Exp Immunol. 2006 Sep;145(3):389-97
references.pmid: 16907905
references.citation: Clin Infect Dis. 2006 Apr 1;42(7):1040-7
references.pmid: 16511773
references.citation: J Clin Microbiol. 2006 Oct;44(10):3539-43
references.pmid: 16928967
references.citation: J Clin Microbiol. 2006 Dec;44(12):4498-510
references.pmid: 17005759
references.citation: J Clin Microbiol. 2001 Oct;39(10):3563-71
references.pmid: 11574573
references.citation: Emerg Infect Dis. 2001 May-Jun;7(3):390-6
references.pmid: 11384514
references.citation: Int J Tuberc Lung Dis. 1997 Apr;1(2):115-21
references.pmid: 9441074
references.citation: N Engl J Med. 2010 Sep 9;363(11):1050-8
references.pmid: 20825317
references.citation: Infect Genet Evol. 2012 Jun;12(4):755-66
references.pmid: 22365971
references.citation: Science. 2006 Jun 30;312(5782):1944-6
references.pmid: 16809538
references.citation: Int J Tuberc Lung Dis. 2012 Jul;16(7):928-33
references.pmid: 22583610
references.citation: Lancet. 2006 Nov 4;368(9547):1575-80
references.pmid: 17084757
references.citation: Int J Tuberc Lung Dis. 2008 Jan;12(1):99-104
references.pmid: 18173885
references.citation: Am J Respir Crit Care Med. 2005 Jun 15;171(12):1430-5
references.pmid: 15831840
references.citation: J Clin Microbiol. 2002 Jun;40(6):1930-7
references.pmid: 12037045
references.citation: Int J Tuberc Lung Dis. 2009 Jun;13(6):767-74
references.pmid: 19460255
references.citation: Lancet. 2002 Mar 2;359(9308):775-80
references.pmid: 11888605
references.citation: FEMS Immunol Med Microbiol. 2004 Nov 1;42(3):281-90
references.pmid: 15477041
references.citation: Int J Tuberc Lung Dis. 2012 Jun;16(6):724-32
references.pmid: 22613684
references.citation: MMWR Morb Mortal Wkly Rep. 2012 Sep 14;61(36):723-5
references.pmid: 22971745
references.citation: BMC Microbiol. 2006 Mar 06;6:23
references.pmid: 16519816
references.citation: N Engl J Med. 2011 Feb 24;364(8):730-9
references.pmid: 21345102
references.citation: J Clin Microbiol. 2007 Jan;45(1):237-40
references.pmid: 17065260
references.citation: J Clin Microbiol. 1997 Apr;35(4):907-14
references.pmid: 9157152
references.citation: Emerg Infect Dis. 2011 Mar;17(3):510-3
references.pmid: 21392446
references.citation: Clin Infect Dis. 2005 Mar 15;40(6):881-6
references.pmid: 15736024
references.citation: Proc Biol Sci. 2001 Jan 7;268(1462):45-52
references.pmid: 12123297
references.citation: Emerg Infect Dis. 2008 Sep;14(9):1345-52
references.pmid: 18759999
references.citation: Emerg Infect Dis. 2010 Feb;16(2):264-71
references.pmid: 20113557
references.citation: J Clin Microbiol. 2009 May;47(5):1484-90
references.pmid: 19297604
references.citation: J Infect Dis. 2012 May 15;205 Suppl 2:S228-40
references.pmid: 22476720
references.citation: N Engl J Med. 2012 Jul 26;367(4):348-61
references.pmid: 22830465
references.citation: Nat Med. 2004 Oct;10(10):1117-21
references.pmid: 15378056
references.citation: Int J Epidemiol. 2011 Aug;40(4):964-70
references.pmid: 21441552
references.citation: Int J Tuberc Lung Dis. 2012 Feb;16(2):192-5
references.pmid: 22236919
references.citation: Int J Tuberc Lung Dis. 2007 Mar;11(3):311-8
references.pmid: 17352098
references.citation: J Clin Microbiol. 2008 Apr;46(4):1514-6
references.pmid: 18272712
references.citation: Lancet. 2012 May 19;379(9829):1902-13
references.pmid: 22608339
references.citation: Tuberculosis (Edinb). 2011 Nov;91(6):510-23
references.pmid: 21835699
references.citation: Lancet. 2010 Jun 19;375(9732):2179-91
references.pmid: 20488521
references.citation: JAMA. 2005 Jun 8;293(22):2726-31
references.pmid: 15941801
references.citation: J Clin Microbiol. 1988 Nov;26(11):2465-6
references.pmid: 3069867
references.citation: Tuberculosis (Edinb). 2009 Mar;89(2):120-5
references.pmid: 19054717
references.citation: Int J Tuberc Lung Dis. 2010 Jan;14(1):119-21
references.pmid: 20003705
references.citation: Science. 1953 Sep 11;118(3063):297-9
references.pmid: 13089681
references.citation: J Clin Microbiol. 2012 Mar;50(3):995-1002
references.pmid: 22170931